Stephens Lawyers & Consultants release guidance on protecting confidential information and trade secrets in Australia
Posted: 17 September 2025 Stephens Lawyers & Consultants recently released an article examining how confidential information and trade secrets are protected under Australian law . The publication emphasised that these assets can easily lose value if improperly disclosed,…
WEHI team awarded 2025 Eureka Prize for Parkinson’s disease research
Posted: 17 September 2025 A research team from WEHI’s Parkinson’s Disease Research Centre was awarded the 2025 Eureka Prize for Scientific Research for discoveries that revealed how a key protein linked to early-onset Parkinson’s disease functions. The Eureka…
Oncology One, Pfizer, WEHI, Cancer Therapeutics CRC and partners advance Australian-discovered KAT6 inhibitor into Phase 3 breast cancer trial
Posted: 17 September 2025 Oncology One Pty Ltd reported that Pfizer Inc’s clinical candidate PF-07248144, a first-in-class KAT6 inhibitor originating from Australian research, had entered a Phase 3 clinical trial for hormone receptor positive, HER2-negative breast cancer. PF-07248144…
Nominations open for the prestigious BioMelbourne Network 2026 Women in Leadership Awards
Posted: 17 September 2025 BioMelbourne Network, the peak industry body for Victoria’s health technologies sector, today announced the launch of the prestigious Women in Leadership Awards (WILA), now in their 11th year. The Awards recognise and champion…
Monash Biotech awarded $750,000 from Brandon BioCatalyst’s CUREator incubator
Posted: 17 September 2025 xCystence Bio, a biotechnology company emerging from Monash University, was awarded a funding boost from Brandon BioCatalyst’s CUREator incubator to accelerate the development of new treatments for Polycystic Kidney Disease (PKD). The supplementary round…
University of Melbourne App advances early Cerebral Palsy diagnosis through at-home screening
Posted: 15 September 2025 A smartphone application created by University of Melbourne researchers was reported to be expediting the diagnosis of cerebral palsy in infants by enabling parents to complete initial screening from home. Cerebral palsy, the most…
Cartherics awarded at 2025 Asia Pacific Cell & Gene Therapy Excellence Awards
Posted: 15 September 2025 Cartherics Pty Ltd was recognised with the title of ‘Most Promising iPSC Therapy Pipeline in APAC’ at the Asia Pacific Cell & Gene Therapy Excellence Awards 2025 (APCGTEA), held in Singapore on 10 September.…
Nutromics secures $7.5 million to advance lab-on-a-patch® platform
Posted: 2 September 2025 Nutromics, a diagnostics innovator based in Melbourne, announced it had raised A$7.5 million in a new acceleration round. The financing was led by a specialist Australian life sciences investor and lifts the company’s cumulative…
4D Medical secures FDA clearance for CT VQ lung imaging technology
Posted: 2 September 2025 4D Medical announced that the US Food and Drug Administration had granted 510(k) clearance for its computed tomography ventilation-perfusion (CT VQ) scan. According to the company, CT VQ is the “first non-contrast imaging modality…
Nucleus Network acquires Hammersmith Medicines Research
Posted: 2 September 2025 Nucleus Network, an international leader in early-stage clinical research, announced it had completed the acquisition of Hammersmith Medicines Research (HMR), one of the United Kingdom’s most highly regarded early-phase trial organisations. This milestone positioned…
Expressions of Interest to join the BioMelbourne Network Board – Nominated and Elected Members
Are you passionate about advancing healthcare through research, innovation, and advocacy in the health technologies sector? BioMelbourne Network (BMN) is a not-for-profit, incorporated organisation and the peak body for Victoria’s health technologies industry. Since 2001, BMN has driven…
Cartherics secure patent from China for enhancing immune cell function
Posted: 27 August 2025 Cartherics announced it had been granted a patent by the Chinese Patent Office for its “Method for Providing Immune Cells with Enhanced Function,” marking a significant milestone in the company’s intellectual property portfolio. The…
